Arvinas Inc (NASDAQ: ARVN) on Monday, soared 4.45% from the previous trading day, before settling in for the closing price of $10.57. Within the past 52 weeks, ARVN’s price has moved between $5.90 and $27.00.
Healthcare Sector giant saw their annual sales slid by -5.32% over the last five years. The company achieved an average annual earnings per share of 74.27%. With a float of $56.70 million, this company’s outstanding shares have now reached $70.80 million.
Arvinas Inc (ARVN) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Arvinas Inc is 11.72%, while institutional ownership is 87.67%. The most recent insider transaction that took place on Nov 07 ’25, was worth 2,275. In this transaction Chief Accounting Officer of this company sold 230 shares at a rate of $9.89, taking the stock ownership to the 31,697 shares. Before that another transaction happened on Sep 22 ’25, when Company’s Director bought 30,000 for $7.57, making the entire transaction worth $227,010. This insider now owns 76,021 shares in total.
Arvinas Inc (ARVN) Earnings and Forecasts
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.63 earnings per share (EPS) for the period topping the consensus outlook (set at -0.96) by 0.33. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.78 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 74.27% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -3.74% during the next five years compared to -5.32% drop over the previous five years of trading.
Arvinas Inc (NASDAQ: ARVN) Trading Performance Indicators
Arvinas Inc (ARVN) is currently performing well based on its current performance indicators. A quick ratio of 5.70 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.27.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.80, a number that is poised to hit -0.51 in the next quarter and is forecasted to reach -3.00 in one year’s time.
Technical Analysis of Arvinas Inc (ARVN)
Analysing the last 5-days average volume posted by the [Arvinas Inc, ARVN], we can find that recorded value of 2.18 million was better than the volume posted last year of 2.18 million. As of the previous 9 days, the stock’s Stochastic %D was 58.33%.
During the past 100 days, Arvinas Inc’s (ARVN) raw stochastic average was set at 91.38%, which indicates a significant increase from 79.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.56 in the past 14 days, which was higher than the 0.44 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.18, while its 200-day Moving Average is $9.24. Now, the first resistance to watch is $11.30. This is followed by the second major resistance level at $11.56. The third major resistance level sits at $12.00. If the price goes on to break the first support level at $10.60, it is likely to go to the next support level at $10.16. Should the price break the second support level, the third support level stands at $9.90.
Arvinas Inc (NASDAQ: ARVN) Key Stats
Market capitalization of the company is 709.04 million based on 64,224K outstanding shares. Right now, sales total 263,400 K and income totals -198,900 K. The company made 41,900 K in profit during its latest quarter, and -35,100 K in sales during its previous quarter.
